Your new post is loading...
Johns Hopkins scientists have identified a molecular marker called 'Mig 6' that appears to accurately predict longer survival—up to two years—among patients prescribed two of the most widely used drugs in a class of anticancer agents called EGFR...
|
Scooped by Graham Player Ph.D. |
Scoop.it!
No comment yet.
Sign up to comment
Scientist have found that high levels of protein production from the Mig 6 gene could predict longer survival in patients who are prescribed anticancer drugs classed as epidermal growth factor receptor (EGFR, also known as ErbB-1 or HER-1) inhibitors. EGFR inhibitors are typically used to slow down or stop cell growth.